Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
Apply
CTX-009 with Gemcitabine, Cisplatin, Durvalumab
CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step